SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 2007; 176: 53255.
  • 2
    Moussas G, Tselebis A, Karkanias A et al. A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases. Ann. Gen. Psychiatry 2008; 7: 7.
  • 3
    Yohannes AM. Depression and COPD in older people: a review and discussion. Br. J. Community Nurs. 2005; 10: 426.
  • 4
    Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2008). 2010.
  • 5
    National Institute for Health and Clinical Excellence. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. 2010.
  • 6
    National Institute for Health and Clinical Excellence. CG91 Depression with a Chronic Physical Health Problem: NICE Guideline. National Collaborating Centre for Mental Health, London, 2009.
  • 7
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC, 2000; 401–10.
  • 8
    Klein DN, Shankman SA, Rose S. Ten-year prospective follow-up study of the naturalistic course of dysthymic disorder and double depression. Am. J. Psychiatry 2006; 163: 87280.
  • 9
    Maurer J, Rebbapragada V, Borson S et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest 2008; 134(4 Suppl.): 43S56S.
  • 10
    van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999; 54: 68892.
  • 11
    Omachi TA, Katz PP, Yelin EH et al. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am. J. Med. 2009; 122: 778.e915.
  • 12
    van Manen JG, Bindels PJ, Dekker FW et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002; 57: 41216.
  • 13
    Jennings JH, Digiovine B, Obeid D et al. The association between depressive symptoms and acute exacerbations of COPD. Lung 2009; 187: 12835.
  • 14
    Cao Z, Ong KC, Eng P et al. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006; 11: 18895.
  • 15
    Ng TP, Niti M, Tan WC et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch. Intern. Med. 2007; 167: 607.
  • 16
    Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom. Med. 2003; 65: 96370.
  • 17
    Vogele C, von Leupoldt A. Mental disorders in chronic obstructive pulmonary disease (COPD). Respir. Med. 2008; 102: 76473.
  • 18
    Gorman JM, Coplan JD. Comorbidity of depression and panic disorder. J. Clin. Psychiatry 1996; 57(Suppl. 10): 3441.
  • 19
    Liebowitz MR. Panic disorder as a chronic illness. J. Clin. Psychiatry 1997; 58(Suppl. 13): 58.
  • 20
    Marcus SC, Olfson M, Pincus HA et al. Self-reported anxiety, general medical conditions, and disability bed days. Am. J. Psychiatry 1997; 154: 17668.
  • 21
    Aydin IO, Ulusahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen. Hosp. Psychiatry 2001; 23: 7783.
  • 22
    Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int. J. Geriatr. Psychiatry 2000; 15: 10906.
  • 23
    Kellner R, Samet J, Pathak D. Dyspnea, anxiety, and depression in chronic respiratory impairment. Gen. Hosp. Psychiatry 1992; 14: 208.
  • 24
    Smith J, Albert P, Bertella E et al. Qualitative aspects of breathlessness in health and disease. Thorax 2009; 64: 71318.
  • 25
    Bernard S, Whittom F, Leblanc P et al. Aerobic and strength training in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999; 159: 896901.
  • 26
    O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2001; 164: 7707.
  • 27
    Kessler RC, Nelson CB, McGonagle KA et al. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br. J. Psychiatry Suppl. 1996; 30: 1730.
  • 28
    Lecrubier Y. The burden of depression and anxiety in general medicine. J. Clin. Psychiatry 2001; 62(Suppl. 8): 49.
  • 29
    National Institute for Health and Clinical Excellence. NICE Clinical Guideline 22 Anxiety (Amended): Management of Anxiety (Panic Disorder, with or without Agoraphobia, and Generalized Anxiety Disorder) in Adults in Primary, Secondary or Community Care. National Institute for Health and Clinical Excellence, London, 2007.
  • 30
    National Institute for Health and Clinical Excellence. Depression in Adults with a Chronic Physical Health Problem: Treatment and Management. National Institute for Health and Clinical Excellence, London, 2009.
  • 31
    National Institute for Health and Clinical Excellence. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults-management in primary, secondary and community care. NICE clinical guideline 113. 2011.
  • 32
    Lasser K, Boyd JW, Woolhandler S et al. Smoking and mental illness: a population-based prevalence study. JAMA 2000; 284: 260610.
  • 33
    Berlin I, Covey LS. Pre-cessation depressive mood predicts failure to quit smoking: the role of coping and personality traits. Addiction 2006; 101: 181421.
  • 34
    Hughes JR. Depression during tobacco abstinence. Nicotine Tob. Res. 2011; 9: 4436.
  • 35
    Segan CJ, Borland R, Wilhelm KA et al. Helping smokers with depression to quit smoking: collaborative care with Quitline. Med. J. Aust. 2011; 195: S711.
  • 36
    Stead LF, Perera R, Bullen C et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 2008; Issue 1, Art. No. CD000146.
  • 37
    Siu EC, Tyndale RF. Non-nicotinic therapies for smoking cessation. Annu. Rev. Pharmacol. Toxicol. 2007; 47: 54164.
  • 38
    Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst. Rev. 2007; Issue 1, Art. No. CD000031.
  • 39
    Strassmann R, Bausch B, Spaar A et al. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur. Respir. J. 2009; 34: 63440.
  • 40
    Lloyd-Williams M, Dennis M, Taylor F. A prospective study to determine the association between physical symptoms and depression in patients with advanced cancer. Palliat. Med. 2004; 18: 55863.
  • 41
    Breitbart W, Rosenfeld B, Pessin H et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 2000; 284: 290711.
  • 42
    Skilbeck J, Mott L, Page H et al. Palliative care in chronic obstructive airways disease: a needs assessment. Palliat. Med. 1998; 12: 24554.
  • 43
    Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax 2000; 55: 10006.
  • 44
    Yohannes AM. Palliative care provision for patients with chronic obstructive pulmonary disease. Health Qual. Life Outcomes 2007; 5: 17.
  • 45
    Mast KR, Salama M, Silverman GK et al. End-of-life content in treatment guidelines for life-limiting diseases. J. Palliat. Med. 2004; 7: 75473.
  • 46
    Elkington H, White P, Addington-Hall J et al. The healthcare needs of chronic obstructive pulmonary disease patients in the last year of life. Palliat. Med. 2005; 19: 48591.
  • 47
    Nici L, Donner C, Wouters E et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2006; 173: 1390413.
  • 48
    Kim HF, Kunik ME, Molinari VA et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000; 41: 46571.
  • 49
    American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am. J. Psychiatry 2000; 157(4 Suppl.): 145.
  • 50
    Thomas PW, Thomas S, Hillier C et al. Psychological interventions for multiple sclerosis. Cochrane Database Syst. Rev. 2006; Issue 1, Art. No. CD004431.
  • 51
    Prins JB, Bleijenberg G, Bazelmans E et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 2001; 357: 8417.
  • 52
    Osborn RL, Demoncada AC, Feuerstein M. Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int. J. Psychiatry Med. 2006; 36: 1334.
  • 53
    Norton PJ, Price EC. A meta-analytic review of adult cognitive-behavioral treatment outcome across the anxiety disorders. J. Nerv. Ment. Dis. 2007; 195: 52131.
  • 54
    Landon TM, Barlow DH. Cognitive-behavioral treatment for panic disorder: current status. J. Psychiatr. Pract. 2004; 10: 21126.
  • 55
    Coventry PA, Gellatly JL. Improving outcomes for COPD patients with mild-to-moderate anxiety and depression: a systematic review of cognitive behavioural therapy. Br. J. Health Psychol. 2008; 13(Pt 3): 381400.
  • 56
    Kunik ME, Veazey C, Cully JA et al. COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of depression and anxiety in COPD patients: a randomized controlled trial. Psychol. Med. 2008; 38: 38596.
  • 57
    Livermore N, Sharpe L, McKenzie D. Prevention of panic attacks and panic disorder in chronic obstructive pulmonary disease. Eur. Respir. J. 2010; 35: 55763.
  • 58
    Ekers D, Richards D, Gilbody S. A meta-analysis of randomized trials of behavioural treatment of depression. Psychol. Med. 2008; 38: 61123.
  • 59
    Usmani ZA, Carson KV, Cheng J et al. Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2011; (11): CD008483.
  • 60
    Light RW, Merrill EJ, Despars J et al. Doxepin treatment of depressed patients with chronic obstructive pulmonary disease. Arch. Intern. Med. 1986; 146: 137780.
  • 61
    Gordon GH, Michiels TM, Mahutte CK et al. Effect of desipramine on control of ventilation and depression scores in patients with severe chronic obstructive pulmonary disease. Psychiatry Res. 1985; 15: 2532.
  • 62
    Eiser N, Harte R, Spiros K et al. Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD 2005; 2: 23341.
  • 63
    Subbe C, Collier GM, Bedson E et al. Pilot study to examine the effect of citalopram on health status, anxiety and depression in patients with chronic obstructive pulmonary disease. clinicaltrials.gov 2004. [Accessed 27 April 2010.] .
  • 64
    Lacasse Y, Beaudoin L, Rousseau L et al. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch. Chest Dis. 2004; 61: 1407.
  • 65
    Montgomery SA. Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients. Int. Clin. Psychopharmacol. 1998; 13(Suppl. 5): S4954.
  • 66
    Nelson DR. The cytochrome p450 homepage. Hum. Genomics 2009; 4: 5965.
  • 67
    Guengerich FP. Cytochrome p450 and chemical toxicology. Chem. Res. Toxicol. 2008; 21: 7083.
  • 68
    Jackson S, Jansen P, Mangoni A. Prescribing for Elderly Patients. John Wiley & Sons, Ltd, Chichester, 2009.
  • 69
    Hiemke C, Hartter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol. Ther. 2000; 85: 1128.
  • 70
    Rossi S, ed. Australian Medicines Handbook 2010. Australian Medicines Handbook, Adelaide, 2010.
  • 71
    Spina E, Scordo MG. Clinically significant drug interactions with antidepressants in the elderly. Drugs Aging 2002; 19: 299320.
  • 72
    Borson S, McDonald GJ, Gayle T et al. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics 1992; 33: 190201.
  • 73
    Puhan MA, Frey M, Buchi S et al. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual. Life Outcomes 2008; 6: 46.
  • 74
    Smoller JW, Pollack MH, Systrom D et al. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics 1998; 39: 249.
  • 75
    Singh NP, Despars JA, Stansbury DW et al. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest 1993; 103: 8004.
  • 76
    Psychotropic Expert Group. Therapeutic Guidelines: Psychotropic. version 6 updated edn. Therapeutic Guidelines Ltd 2008, Melbourne, 2009.
  • 77
    Weiss KJ. Management of anxiety and depression syndromes in the elderly. J. Clin. Psychiatry 1994; 55(Suppl.): 512.
  • 78
    Bourin M. Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review. Hum. Psychopharmacol. 2003; 18: 18590.
  • 79
    Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin. Neuropharmacol. 2005; 28: 20514.
  • 80
    Rottmann CN. SSRIs and the syndrome of inappropriate antidiuretic hormone secretion. Am. J. Nurs. 2007; 107: 518.
  • 81
    Alderman CP, Frith PA. Fluvoxamine-methadone interaction. Aust. N. Z. J. Psychiatry 1999; 33: 99101.
  • 82
    Rief W, Nestoriuc Y, Lilienfeld-Toal A et al. Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis. Drug Saf. 2009; 32: 104156.
  • 83
    Richards JB, Papaioannou A, Adachi JD et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch. Intern. Med. 2007; 167: 18894.
  • 84
    Hubbard R, Farrington P, Smith C et al. Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am. J. Epidemiol. 2003; 158: 7784.
  • 85
    Vestergaard P. Fracture risks of antidepressants. Expert Rev. Neurother. 2009; 9: 13741.
  • 86
    Schols AM, Slangen J, Volovics L et al. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157(6 Pt 1): 17917.
  • 87
    Furukawa TA, Streiner DL, Young LT. Antidepressant and benzodiazepine for major depression. Cochrane Database Syst. Rev. 2002; Issue 1, Art. No. CD001026.
  • 88
    Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2008). 2008. Medical Communication Resources.
  • 89
    McKenzie DK, Frith PA, Burdon JG et al. The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003. Med. J. Aust. 2003; 178(Suppl.): S739.
  • 90
    Lacasse Y, Martin S, Lasserson TJ et al. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura. Medicophys. 2007; 43: 47585.
  • 91
    Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J. Psychosom. Res. 2007; 63: 55165.
  • 92
    Coventry PA. Does pulmonary rehabilitation reduce anxiety and depression in chronic obstructive pulmonary disease? Curr. Opin. Pulm. Med. 2009; 15: 1439.
  • 93
    Man WD, Polkey MI, Donaldson N et al. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004; 329: 1209.
  • 94
    Benson H, Beary JF, Carol MP. The relaxation response. Psychiatry 1974; 37: 3746.
  • 95
    Mandle CL, Jacobs SC, Arcari PM et al. The efficacy of relaxation response interventions with adult patients: a review of the literature. J. Cardiovasc. Nurs. 1996; 10: 426.
  • 96
    Devine EC, Pearcy J. Meta-analysis of the effects of psychoeducational care in adults with chronic obstructive pulmonary disease. Patient Educ. Couns. 1996; 29: 16778.
  • 97
    Morrison RS, Meier DE. Clinical practice. Palliative care. N. Engl. J. Med. 2004; 350: 258290.
  • 98
    Aiken LS, Butner J, Lockhart CA et al. Outcome evaluation of a randomized trial of the PhoenixCare intervention: program of case management and coordinated care for the seriously chronically ill. J. Palliat. Med. 2006; 9: 11126.
  • 99
    Klerman GL, Weissman MM. New Applications of Interpersonal Psychotherapy. American Psychiatric Press, Washington, DC, 1993.
  • 100
    Judd F, Weissman M, Davis J et al. Interpersonal counselling in general practice. Aust. Fam. Physician 2004; 33: 3327.
  • 101
    Markowitz JC, Weissman MM. Interpersonal psychotherapy: principles and applications. World Psychiatry 2004; 3: 1369.
  • 102
    Lipsitz JD, Gur M, Vermes D et al. A randomized trial of interpersonal therapy versus supportive therapy for social anxiety disorder. Depress. Anxiety 2008; 25: 54253.
  • 103
    Miller MD. Using interpersonal therapy (IPT) with older adults today and tomorrow: a review of the literature and new developments. Curr. Psychiatry Rep. 2008; 10: 1622.
  • 104
    Bourbeau J, Julien M, Maltais F et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch. Intern. Med. 2003; 163: 58591.
  • 105
    Jonker AA, Comijs HC, Knipscheer KC et al. Promotion of self-management in vulnerable older people: a narrative literature review of outcomes of the Chronic Disease Self-Management Program (CDSMP). Eur. J. Ageing 2009; 6: 30314.
  • 106
    Kroenke K, Bair MJ, Damush TM et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 2009; 301: 2099110.
  • 107
    Effing T, Monninkhof EM, van der Valk PD et al. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2007; Issue 4, Art No. CD002990.
  • 108
    Effing T, Kerstjens H, van der Valk P et al. Cost)-effectiveness of self-treatment of exacerbations on the severity of exacerbations in patients with COPD: the COPE II study. Thorax 2009; 64: 95662.
  • 109
    Cockcroft A, Bagnall P, Heslop A et al. Controlled trial of respiratory health worker visiting patients with chronic respiratory disability. Br. Med. J. (Clin. Res. Ed) 1987; 294: 2258.
  • 110
    Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996; 74: 51144.
  • 111
    Rollman BL, Belnap BH, Mazumdar S et al. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch. Gen. Psychiatry 2005; 62: 133241.
  • 112
    Neumeyer-Gromen A, Lampert T, Stark K et al. Disease management programs for depression: a systematic review and meta-analysis of randomized controlled trials. Med. Care 2004; 42: 121121.
  • 113
    Ram FS, Wedzicha JA, Wright J et al. Hospital at home for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2003; Issue 4, Art. No. CD003573.
  • 114
    Hernandez C, Casas A, Escarrabill J et al. Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. Eur. Respir. J. 2003; 21: 5867.
  • 115
    Aimonino RN, Tibaldi V, Leff B et al. Substitutive ‘hospital at home’ versus inpatient care for elderly patients with exacerbations of chronic obstructive pulmonary disease: a prospective randomized, controlled trial. J. Am. Geriatr. Soc. 2008; 56: 493500.
  • 116
    Novalis PN, Rojcewicz SJ Jr, Peele R. Clinical Manual of Supportive Psychotherapy, 1st edn. American Psychiatric Press, Washington, DC, 1993.
  • 117
    Pinsker H, Rosenthal RE. Supportive Therapy Treatment Manual. Social and Behavioral Sciences Documents, Corte Madera, CA, 1988.
  • 118
    Ayers CR, Sorrell JT, Thorp SR et al. Evidence-based psychological treatments for late-life anxiety. Psychol. Aging 2007; 22: 817.
  • 119
    Krause M. The transformation of social representations of chronic disease in a self-help group. J. Health Psychol. 2003; 8: 599615.
  • 120
    Cohen S, Syme LC. Issues in the study and application of social support. In: Cohen S, Syme LC (eds) Social Support and Health. Academic Press, New York, 1985; 322.
  • 121
    Jackson AM, Gregory S, McKinstry B. Self-help groups for patients with coronary heart disease as a resource for rehabilitation and secondary prevention-what is the evidence? Heart Lung 2009; 38: 192200.
  • 122
    Branckaerts J, Richardson A. Self-help groups: their impact and potential. WHO Reg. Publ. Eur. Ser. 1992; 44: 3637.